This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife (MET) Expands Coverage to Include Diabetic Patients
by Zacks Equity Research
The expansion of coverage by MetLife Hong Kong, a wholly owned subsidiary of MetLife (MET), intends to make medical facilities easily accessible for diabetic patients.
MetLife's Logan Circle Buy to Boost Investment Management
by Zacks Equity Research
MetLife's (MET) $250 million buyout of Logan Circle primarily aims at strengthening the acquirer's investment management expertise.
Why Is MetLife (MET) Down 11.5% Since the Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insurance Stocks to Endure the Wrath of Hurricane Harvey
by Zacks Equity Research
Property and casualty stocks might witness an earnings drain due to hurricane Harvey, but the event is expected to benefit them in the form of increased premium prices.
Forget MetLife (MET), Buy These 3 Insurance Stocks Instead
by Zacks Equity Research
MetLife's (MET) declining revenues from low premiums, fees and other revenues, macroeconomic factors, and low return on equity make it an unattractive stock now.
The Zacks Analyst Blog Highlights: CVS Health, Marriott, Enbridge, MetLife and Aon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CVS Health, Marriott, Enbridge, MetLife and Aon
MetLife Suffers From Declining Revenues, Spinoff Charges
by Zacks Equity Research
MetLife's (MET) declining revenues, low premiums, fees and other revenues continue to bother.
Top Stock Reports for CVS Health, Marriott & Enbridge
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including CVS Health (CVS), Marriott (MAR), and Enbridge (ENB).
Are Options Traders Betting on a Big Move in MetLife (MET) Stock?
by Zacks Equity Research
Investors in MetLife (MET) need to pay close attention to the stock based on moves in the options market lately.
AIG Q2 Earnings Beat as Restructuring Initiatives Pay Off
by Zacks Equity Research
American International Group Inc.'s (AIG) second-quarter results benefit from favorable performance by its consumer business, cost control efforts and share buyback.
MetLife (MET) Earnings Beat Estimates in Q2, Improve Y/Y
by Zacks Equity Research
MetLife's (MET) solid Q2 results were driven by the strong performance of all the segments.
MetLife (MET) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Metlife's (MET) second-quarter earnings may gain from higher sales in group benefit and efficient capital management. Derivative losses and foreign exchange volatility may hurt.
Fortress (FIG) to Divest Logan Circle Partners, Stock Down
by Zacks Equity Research
Fortress Investment Group LLC (FIG) entered into an agreement to divest its 100% stake in Logan Circle Partners to MetLife, Inc. (MET).
MetLife to Buy Logan Circle, Expand Investment Management
by Zacks Equity Research
MetLife, Inc. (MET) has entered into a definitive agreement with Fortress Investment to acquire its fixed income asset management business.
MetLife's (MET) Board Okays Brighthouse Spin-Off, Stock Up
by Zacks Equity Research
MetLife, Inc.'s (MET) board of directors has given a green signal to the spin-off of its U.S. life insurance unit named Brighthouse Financial Inc.
Will Changes in Top Brass Boost MetLife's (MET) Growth?
by Zacks Equity Research
MetLife (MET) announced a host of management changes to its top leadership team, which will be effective Jul 1.
Why Is MetLife (MET) Down 1.9% Since the Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Highwoods to Develop MetLife's Office Building in Weston
by Zacks Equity Research
Highwoods Properties, Inc. (HIW) announced that it has been selected by MetLife, Inc. (MET) to develop a third office building for its global technology campus in Cary's mixed-use Weston planned unit development.
The Zacks Analyst Blog Highlights: Gilead, Dow Chemical, MetLife, Tesla and Emerson Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Gilead, Dow Chemical, MetLife, Tesla and Emerson Electric
MetLife (MET) Q1 Earnings & Revenues Top Estimates, Grow Y/Y
by Zacks Equity Research
MetLife, Inc.'s (MET) earnings of $1.46 per share beat the Zacks Consensus Estimate by 14.96% and were up 12.3% year over year.
AIG (AIG) Beats on Q1 Earnings, Growth Initiatives On Track
by Zacks Equity Research
American International Group Inc. (AIG) eanings of $1.36 per share surpassed the Zacks Consensus Estimate by a good 22.5%.
Insurance Stocks Q1 Earnings on May 3: AIG, MET, LNC, PRU
by Zacks Equity Research
The Q1 earnings season is in full swing with 57.6% members of the elite S&P 500 Index reporting solid quarterly numbers so far.
What's in Store for MetLife (MET) this Earnings Season?
by Zacks Equity Research
MetLife Inc. (MET) is scheduled to report first-quarter 2017 results on May 3, after market close.
What's in Store for The Hartford (HIG) this Earnings Season?
by Zacks Equity Research
The Hartford Financial Services Group, Inc. (HIG) will release first-quarter 2017 financial results on Apr 27, after the closing bell.
Profit from These 5 Sturdy Stocks as Fear Grips Markets
by Tirthankar Chakraborty
Wall Street's fear gauge is breaking out higher as geopolitical risks heat up after the U.S. opted for 'Mother of All Bombs'.